19357A: Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 years) for the Preventive Treatment of Episodic Migraine

Grants and Contracts Details

StatusActive
Effective start/end date5/12/235/12/25

Funding

  • H. Lundbeck A/S: $2.00